52nd week of 2009 patent applcation highlights part 38 |
Patent application number | Title | Published |
20090317441 | BIOENGINEERED TISSUE CONSTRUCTS AND CARDIAC USES THEREOF - Cultured tissue constructs comprising cultured cells and endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. Some tissue constructs of the invention are comprised of multiple cell layers or more than one cell type. The tissue constructs of the invention have morphological features and functions similar to tissues their cells are derived and their strength makes them easily handleable. Preferred cultured tissue constructs of the invention are prepared in defined media, that is, without the addition of chemically undefined components. These tissue constructs are used to repair cardiac tissues. | 2009-12-24 |
20090317442 | Super Elastic Epoxy Hydrogel - Described is a super elastic epoxy hydrogel that is easy to manufacture and can be engineered for various performance enhancements of the polymer. Also described are methods of enhancing the performance of this hydrogel and other hydrogels. Various polymer hydrogel composites, structures, and their uses are included, such as the actuator element comprising the hydrogel of the invention depicted in FIG. | 2009-12-24 |
20090317443 | COATED IMPLANT - A method forming a coated implant is described. The implant comprises a surface which is first coated with a primer and subsequently with a biocompatible polymer capable of forming a covalent bond to the primer. The polymer coating is then crosslinked. The invention also relates to implants, in particular, stents, coated with such a coating. | 2009-12-24 |
20090317444 | PROCESS FOR CELL PROLIFERATION - In vitro process for the proliferation or culture of conjunctive tissue cells selected from the group consisting of chondrocytes, osteoblasts, chondroprogenitor cells, osteoprogenitor cells, tenocytes and ligament cells comprising the step of contacting said cells with an aminosugar selected from the group consisting of mannosamine, N-acetylmannosamine, mannosamine salts and their mixtures. The present invention also relates to compositions which comprise the aminosugar in combination with the cells. These compositions are useful for the treatment of cartilage, bone, tendon and ligament lesions or defects, bone mass losses and osteochondral defects or lesions. | 2009-12-24 |
20090317445 | DRUG DELIVERY SYSTEM WITH THERMOSWITCHABLE MEMBRANES - The present invention provides a device for controlled release of molecules. The device is particularly suitable for controlled release of therapeutic drugs to a patient. The device includes a housing with an opening for release of the molecules from the housing. The housing also comprises a reservoir for containing the molecules, in particular therapeutic drugs. The reservoir is arranged in the housing to allow release of the molecules through the opening. The device also comprises at least one thermoswitchable membrane and at least one heating element for at least partially heating the membrane. The device is configured for modulating the release of the molecules at the opening by heating the membrane, using the heating element. Optionally, the device further comprises a pressure element for providing pressurized release of the molecules from the device. In this way, the drug can be delivered to a patient in a pulsatile fashion. The present invention also provides a method for modulating the release of molecules, using such a device. | 2009-12-24 |
20090317446 | Calcium Phosphate Nanofibers - Calcium-phosphate nanofiber matrices comprising randomly dispersed crystalline calcium-phosphate nanofibers are provided. The nanofibers are synthesized using sol-gel methods combined with electrospinning. The nanofibers may be hollow, solid or may comprise a calcium-phosphate shell surrounding a polymer containing inner core to which biologically functional additives may be added. The nanofiber matrices may be used to culture bone and dental cells, and as implants to treat bone, dental or periodontal diseases and defects. | 2009-12-24 |
20090317447 | Biodegradable bone graft for orthopedic use - In the present invention, a biodegradable bone graft is disclosed, which includes: a scaffold made of a biodegradable material; and a collagen-embedding matrix portion which completely encompasses the scaffold. The above-mentioned bone graft can increase the micro-porosity of the scaffold to enable cells to grow adhesively thereon. Compared with the scaffold only, the above-mentioned bone graft has high hydrophilicity. Hence, the bone graft of the present invention can efficiently retain tissue fluid, cell growth factors, blood and/or bone marrow which are mixed with the bone graft beforehand to achieve osteoinduction. Furthermore, the collagen-embedding matrix portion can also serve as a carrier to encompass other bone graft materials and drug molecules. The present invention also relates to a method for manufacturing the above-mentioned bone graft. | 2009-12-24 |
20090317448 | TYMPANIC MEMBRANE PATCH - The invention features methods of making living tissue constructs that can be used to repair perforations in tympanic membranes, the repair constructs themselves, and methods of repair. | 2009-12-24 |
20090317449 | ANIMAL FOOD PACKAGE WITH CHEWABLE SCOOP TO PROMOTE DENTAL HEALTH - An edible animal food scoop formulated to promote dental health is provided. The edible animal food scoop is used to dispense animal food from a container and, typically when the container is empty, is provided to the animal for chewing or consumption. Over the time the edible food scoop is used and/or in contact with the food, the edible scoop absorbs the flavor and/or scent of the animal food to move from a first flavor and/or scent to a second flavor and/or scent associated with the animal food to entice the animal into chewing or consuming the edible food scoop. Chewing the edible animal food scoop facilitates dental health. | 2009-12-24 |
20090317450 | PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION - Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described. | 2009-12-24 |
20090317451 | PRESSURE-SENSITIVE ADHESIVE FOR SKIN SURFACE AND/OR TRANSDERMAL SUBSTANCE DELIVERY - A pressure-sensitive adhesive composition is described having a reservoir of medication or other substance and capable of intimate contact with a target area of skin, rapid conveyance of the medication onto and/or into the target area, and ready removal from the area of skin using water. Polyvinylpyrrolidone and glycerol mixtures have been found to dissolve a large number of medications while producing a self-tackifying, pressure-sensitive adhesive composition. | 2009-12-24 |
20090317452 | Transdermal patch - The present invention provides a transdermal patch having excellent preservation stability and transdermal absorbency of DMAE or its pharmacologically acceptable salt. The patch has a support and a plaster layer integrally laminated on one surface of the support, and the plaster layer includes: 2-amino-1-(2′,5′-dimethoxyphenyl)ethanol or its pharmacologically acceptable salt; 40 to 98% by weight of acrylic adhesive prepared by copolymerizing monomers respectively containing 30 to 99% by weight of alkyl methacrylate having an alkyl group with a carbon number of 6 to 22 and 1 to 70% by weight of alkyl acrylate having an alkyl group with a carbon number of 2 to 20; and 1 to 30% by weight of saturated aliphatic monohydric alcohol having an alkyl group with a carbon number of 10 to 30. | 2009-12-24 |
20090317453 | TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS - Methods are provided for enhancing the permeability of skin or mucosal tissue to topical or transdermal application of pharmacologically or cosmeceutically active agents. The methods entail the use of a base in order to increase the flux of the active agent through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. The permeation enhancer can be an inorganic or organic base. Compositions and transdermal systems are also described. | 2009-12-24 |
20090317454 | Body or plant part dressing - A dressing having a flexible sleeve shaped to accommodate a substantially cylindrical body or plant portion, the sleeve having a lining which is substantially non-adherent to the body or plant part being bandaged and having a peripheral securement means which attaches two peripheral portions to each other without those portions being circumferentially adhered to the sleeve portion. | 2009-12-24 |
20090317455 | REVERSE TARGETING LIPID VESICLE - The present invention provides an immunomodulating agent and a therapeutic agent for a immune disease, which comprise a lipid vesicle encapsulating a drug capable of suppressing or damaging an immunocyte that expresses or binds to an antibody, the lipid vesicle having an antigen for the antibody bound to the outer surface thereof. Hence, there is provided means for effectively treating an immune disease such as an allergic diseases or an autoimmune disease. | 2009-12-24 |
20090317456 | USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCER - The present invention relates to a combination of at least one oncolytic virus and at least one antiangiogenic agent and to the use of this combination in tumor therapy. | 2009-12-24 |
20090317457 | ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN B-4 - The invention relates to a method of treating inflammatory conditions in a subject comprising administering to a subject a composition comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also provides a method of promoting wound healing in a subject comprising administering to the subject a composition comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also relates to methods of treating the above mentioned conditions in a subject comprising administering to the subject a nucleic acid encoding a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also relates to pharmaceutical compositions comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant, or salt thereof, and a pharmaceutically acceptable carrier. | 2009-12-24 |
20090317458 | Fluid-jet pens configured for making modulated release bioactive agents - The present invention is drawn to methods of preparing a bioactive agent-containing emulsion for delivery to a biological system. This method can comprise the step of jetting a bioactive agent and a first fluid medium from a fluid-jet pen into a second fluid medium to form a bioactive agent-containing emulsion, wherein the second fluid comprises a continuous phase of the emulsion. Alternatively, a method of preparing a bioactive agent-containing liposome can comprise jetting a lipid-containing composition and a bioactive agent from a fluid-jet pen into a medium to form a bioactive agent-containing liposome carried by the medium. The present invention is also drawn to fluid-jet pens and systems configured for making liposome- and emulsion-containing biological agents. | 2009-12-24 |
20090317459 | Material - There is provided a granular material comprising (i) at least 50% by weight based on the weight of the granular material of solid water-insoluble mixed metal compound capable of binding phosphate of formula (I): M | 2009-12-24 |
20090317460 | SOLID DOSAGE FORM - A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof. | 2009-12-24 |
20090317461 | ORAL COMPOSITIONS EFFECTIVE FOR THE TREATMENT OF ORAL CAVITY MALODOR ASSOCIATED WITH THE CONSUMPTION OF ODOR-CAUSING COMPOUNDS - This invention generally relates to oral compositions (e.g., a confection or chewing gum product) effective for the treatment of oral cavity malodor caused by odor-causing compounds (e.g., diallyl disulfide) associated with the consumption of, for example, garlic and/or onion. In particular, this invention relates to oral compositions containing menthone, isomenthone and, optionally, caryophyllene in varying concentrations, to provide an oral composition effective for the treatment of oral cavity malodor caused by odor-causing compounds associated with the consumption of, for example, garlic and onion. | 2009-12-24 |
20090317462 | PEPTIDE PHARMACEUTICAL FOR ORAL DELIVERY - Acid-containing oral pharmaceutical compositions are provided wherein the pharmaceutical active agents are peptide compounds (i.e., those that include a plurality of amino acids and at least one peptide bond in their molecular structures). Certain barrier layers and/or particulate coated acid are used to reduce any adverse interactions that might otherwise occur between the acid of the compositions and other components of the composition. Use of these barrier layers and/or use of particulate coated acid is believed to promote a more simultaneous release of the components of the composition than is achieved by prior art acid-protection techniques, thus enhancing, and making more consistent, the bioavailability of the active peptide compounds. | 2009-12-24 |
20090317463 | COMPOSITION FOR ORAL USE BASED ON S-ADENOSYLMETHIONINE AND A PROCESS FOR THEIR PREPARATION - The present invention relates to solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on SAMe, or salts thereof, in combination with inositol and/or derivatives thereof and to a process for their preparation. The present invention relates to a method of stabilising a solid composition for oral use based on SAMe or salts thereof, making use of inositol and/or derivatives thereof with the addition of magnesium oxide. The present invention also relates to the use of SAMe, or salts thereof, in combination with inositol and/or derivatives thereof with the possible further addition of melatonine, St. John's Wort and/or lemon balm for the treatment of depressive states and/or panic syndromes. | 2009-12-24 |
20090317464 | METHODS AND COMPOSITIONS FOR PRODUCING ANTI-ANDROGENIC EFFECTS - The invention provides a method and a composition for producing an anti-androgenic effect in a mammal. The method comprises administering a modified release pharmaceutical composition of bicalutamide to a mammal, with a reduced dosing frequency, for improved patient convenience and compliance. The composition of the invention also provides for a higher bioavailability and improved pharmacokinetic profile as compared to a conventional bicalutamide composition. | 2009-12-24 |
20090317465 | COMPOSITION AND METHOD OF PREPARATION OF RELEASE SYSTEMS FOR CONSTANT (ZERO-ORDER) RELEASE OF ACTIVE AGENTS - The present invention includes methods and compositions for pharmaceutical compositions that exhibit substantially constant release profile. The composition includes at least two layers with different drug to polymer ratios. The layers can be arranged in any order to achieve desirable pharmaceutical effects. | 2009-12-24 |
20090317466 | Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine - Pharmaceutical composition, containing fixed doses of hydroxyurea and didanosine, a method of manufacturing such composition, and to the use of the composition for the treatment of retroviral infections. | 2009-12-24 |
20090317467 | HYDROCOLLOID COMPOSITION - A therapeutic composition is described comprising a particulate dispersion of a hydrocolloid in a low water activity anti-microbial matrix. The composition may also contain any or all of a sequestrant, excipient, carrier and surfactant. The hydrocolloid may be naturally occurring, semisynthetic or synthetic. The invention extends to a method of producing a therapeutic composition. The composition is prepared by mixing a low water activity anti-microbial matrix with hydrocolloid particles at a temperature that will not cause degradation of the matrix. The method may also include the addition of other components such as excipients, sequestrants, carriers and surfactants and other agents. The invention extends to methods for treating a human or animal subject by applying or administering the composition to the subject subject in a therapeutically effective dose. | 2009-12-24 |
20090317468 | MULTICOMPARTMENT GRANULATE FORMULATIONS FOR ACTIVE SUBSTANCES - The invention relates to molded article that contains active substances and comprises at least two compartments that have a different material composition. Each compartment is independently provided with at least one active substance that is contained in a matrix. Each matrix encompasses at least one filler at a concentration of ≧20 percent by weight to ≦100 percent by weight relative to the total weight of the respective matrix. The invention further relates to a method for producing such molded articles as well as the use thereof. | 2009-12-24 |
20090317469 | COMPOSITE EXTRACELLULAR MATRIX MATERIALS AND MEDICAL PRODUCTS FORMED THEREFROM - Described in certain aspects are composite extracellular matrix material products including expanded collagenous materials in combination with non-expanded collagenous materials. Methods for their preparation and use are also disclosed. Certain expanded collagenous materials can be prepared by treating a first collagenous material with an alkaline substance under conditions effective to expand the first collagenous material, and recovering the expanded material. Expanded materials can exhibit beneficial persistence and tissue generation characteristics when implanted, and can be used in the formation of highly porous medical implant bodies which can be compressed to fractions of their original volume and will thereafter substantially recover their original volume. | 2009-12-24 |
20090317470 | Oramucosal Pharmaceutical Dosage Form - This invention relates to an oramucosal pharmaceutical dosage form in the form of a wafer. The wafer comprises a porous, hydroscopic, muco-adhesive polymeric matrix with at least one desired pharmaceutically active compound added thereto. The polymer is selected from a number of polymers having different dissolution rates and, in use when taken orally, the matrix adheres to an oramucosal surface to dissolve over a predetermined period of time to release the pharmaceutically active compound. The invention also extends to a method of manufacturing an oramucosal pharmaceutical dosage form in the form of a wafer which involves freeze drying or lyophilisation. | 2009-12-24 |
20090317471 | CONTROLLED-RELEASE FORMULATIONS, METHOD OF MANUFACTURE, AND USE THEREOF - The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt or solvate thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient and does not contain a functional coating or a lipophilic component. The present invention also provides methods of making and using the controlled-release compositions. | 2009-12-24 |
20090317472 | CONTROLLED RELEASES OF ACTIVES IN SKIN - Topical compositions are provided in which active compounds for topical delivery through the stratum corneum are complexed with nanospheres of a triblock copolymer having an A-B-A structure wherein each A end block is a water-soluble, hydrophilic and non-toxic polymer or oligomer; and the hydrophobic middle B block is a hydrophobic polymer or oligomer with the same or different repeating units having the structure according to formula:(I) wherein X is —C —R—C— or —C—; Z is between 2 and about 100, inclusive; R | 2009-12-24 |
20090317473 | CONTROLLED-RELEASE FORMULATIONS, METHOD OF MANUFACTURE, AND USE THEREOF - The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt, solvate, ester, and/or prodrug thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient. The present invention also provides methods of making and using the controlled-release compositions. | 2009-12-24 |
20090317474 | USE OF POLYETHYLENE GLYCOL IN INFLAMMATION RELATED TOPICAL DISORDERS OR DISEASES AND WOUND HEALING - The present invention relates to hydrogel compositions or aqueous solutions comprising one or more forms of Poly-ethylene Glycol, for use as medicaments, more particularly for topical application in the treatment of wounds, for the treatment of inflammatory skin disease and in particular for the prevention of scar formation and/or for enhancing the repair of damaged skin or mucosa. | 2009-12-24 |
20090317475 | COMBINATION ANTITUMOR THERAPIES - Improved methods of treating cancers that are characterized by unwanted angiogenesis employ combinations of therapies designed to inhibit the VEGF mediated angiogenesis pathway with therapies designed to inhibit the bFGF-mediated angiogenesis pathway. | 2009-12-24 |
20090317476 | COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent comprising a leukotriene receptor antagonist for the treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases. | 2009-12-24 |
20090317477 | COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A GLUCOCORTICOSTEROID FOR TREATMENT OF ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE OR ALLERGIC RHINITIS - A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent comprising a glucocorticosteroid for the treatment of asthma, chronic obstructive pulmonary disease, allergic rhinitis, or any other respiratory disease. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or any other respiratory disease. | 2009-12-24 |
20090317478 | METHOD OF PREPARING COVERED POROUS BIODEGRADABLE POLYMER MICROSPHERES FOR SUSTAINED-RELEASE DRUG DELIVERY AND TISSUE REGENERATION - The present invention relates to covered porous biodegradable polymer microspheres for sustained-release drug delivery and tissue regeneration which has an interconnected inner open pore structure having a wide surface area and high porosity and an outer closed pore structure in which the surface of the microsphere is covered with a thin layer of a biodegradable polymer, and thereby the pores formed on the surface and exposed to the outside are closed; and methods for preparing the same. Due to such a characteristic pore structure, the covered porous biodegradable polymer microspheres according to the present invention can prevent the biologically active material from being excessively released in the early stage immediately after administration, and after that, can gradually release the biologically active material through the interconnected inner pore structure over a prolonged period as the biodegradable polymer thin layer is degraded. Therefore, the microsphere of the present invention can be effectively used for sustained-release drug delivery and tissue regeneration. | 2009-12-24 |
20090317479 | NANOPARTICLES CONTAINING WATER-SOLUBLE NON-PEPTIDE LOW-MOLECULAR WEIGHT DRUG - Drug-containing nanoparticles are provided that enable effective targeting and sustained-release of a water-soluble, non-peptide, low-molecular weight drug and cause reduced accumulation of the drug in the liver. The nanoparticles containing a water-soluble, non-peptide, low-molecular weight drug are obtained by hydrophobicizing the water-soluble, non-peptide, low-molecular weight drug by a metal ion, and reacting the hydrophobicized drug with a poly(lactic acid)-polyethylene glycol block copolymer or a poly(lactic-co-glycolic acid)-polyethylene glycol block copolymer. The nanoparticles have favorable targeting and sustained-release properties and cause reduced accumulation of the drug in the liver. | 2009-12-24 |
20090317480 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-II - The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds. | 2009-12-24 |
20090317481 | MODAFINIL FORMULATIONS - The invention provides an oral pharmaceutical composition comprising modafinil particles, wherein at least about 5% of said modafinil particles have a diameter greater than 200 microns. | 2009-12-24 |
20090317482 | METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE - Compositions and methods for treating congestive heart failure are provided herein. | 2009-12-24 |
20090317483 | Bicomponent Bioadhesive for Biomedical Use - The invention relates to new biocomponent bioadhesive formulations, with a synthetic part and an autologous biological part of blood origin comprising plasma rich in platelets and in growth factors, and its use of same in biomedicine, preferably in opththalmic surgery. | 2009-12-24 |
20090317484 | SALIVARY SUBSTITUTE - A salivary substitute is produced from egg white so as to have chemical, rheological and physiological properties that are analogous to those of natural human saliva. A packaging containing the salivary substitute and uses of the salivary substitute are also disclosed. | 2009-12-24 |
20090317485 | Skin Protectant Spray Compositions - A liquid, water-repellent, substantially anhydrous, spray-pumpable skin protectant composition is disclosed. The composition is designed for spraying directly onto skin, has suitable adherence to the skin, and resists running. The composition contains one or more actives, one or more rheology modifiers, and a carrier. The rheological modifiers can be waxes and/or associative thickeners such as some forms of silica. The carrier can be mineral oil or a mineral oil replacement (e.g., isohexadecane, cyclomethicone). Film-forming components also help the composition resist running. One indication for which the composition may be formulated is diaper rash. The active ingredient for diaper rash may be dimethicone and preferably also zinc oxide. | 2009-12-24 |
20090317486 | WEEKLY FLOATER POOL SANITIZER - A composition for the treatment of a liquid, particularly a body of water, such as a swimming pool, spa, or the like. The composition includes calcium hypochlorite, a water soluble zinc salt for controlling algae, and sodium aluminate as an agglomerating agent that may safely be combined with said calcium hypochlorite and said zinc salt. A floating chemical dispenser for containing and dispensing chemicals to treat a body of water. The dispenser includes an upper end float, a container adapted to contain chemicals, the container removably joined with the upper end float, and a free end float joined with the container. The free end float is configured so that a central axis of the container and upper end float is not substantially orthogonal to a surface of the water. | 2009-12-24 |
20090317487 | KITS FOR PREVENTION AND TREATMENT OF RHINITIS - Kits providing a combination of one or more pharmaceutical information comprising one or more agent(s) for the treatment or alleviation of symptoms commonly associated with a cold and an immunonutritional composition comprising immunonutritional agent and methods of using these kits are described. The kits provide both the pharmaceutical agent(s) and the immunonutritional agent in a convenient form for administration. The kit typically includes instruction for coordinating the administration of the pharmaceutical formulation with the administration of the immunonutritional composition. The preferred immunonutritional agents are compounds that contain a pharmaceutically acceptable form of zinc, such as zinc acetate, zinc gluconate, zinc gluconate glycine, and zinc sulfate. Preferably the kit contains multiple dosage forms containing the immunonutritional composition. In the most preferred embodiment, the immunonutritional composition is in the form of a lozenge. Suitable pharmaceutical agents include but are not limited to antihistamines, decongestants, anticholinergics, antitussives, analgesics, mucolytics, expectorants, and combinations thereof. The pharmaceutical formulations may be in any suitable dosage form, including forms which provide controlled release of the pharmaceutical agent, including immediate, sustained, modified, delayed or pulsed release pharmacokinetic mechanism or a combination thereof. The combined treatment requires administration of both the pharmaceutical formulation(s) for the treatment of symptoms commonly associated with a cold and the administration of the immunonutritional composition, which supplies nutritional support for the patient's innate immune response to the presence of infectious organisms. | 2009-12-24 |
20090317488 | Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof - A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations. | 2009-12-24 |
20090317489 | Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof - The present invention relates to a combination comprising a a substituted 3,5-diphenyl-1,2,4-triazole, e.g. 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and at least one anti-neoplastic agent and to the use of said combination for the preparation of a medicament for the treatment of proliferative diseases. | 2009-12-24 |
20090317490 | SUBSTITUTED CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY - Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described. | 2009-12-24 |
20090317491 | MANUFACTURING METHOD OF MEDICAL STERILIZED ISOTONIC SOLUTION HAVING LOW-CONCENTRATEDLY CONTROLLED FREE CHLORINE INCLUDING HYPOCHLOROUS ACID THEREIN - The present invention relates to a manufacturing method of medical sterilized normal saline, more specifically, to such a method for manufacturing sterilized normal saline for medical purpose with effective sterilizing efficacy comprising: a step of disposing at least one electrode set immersed in saline solution of pH 4.0 to pH 7.5 including a pair of electrodes with flat surface separated from each other by an interval between 1 mm and 3 mm, the flat surfaces of the electrodes facing each other; and a step of supplying 3 OmA to 20 OmA direct current to the electrodes by applying 2.4V to 3.3V DC power to the electrodes; wherein free chlorine is reliably and stably generated as having concentration range between 0.17 ppm and 6 ppm from electrolysis between electrodes. | 2009-12-24 |
20090317492 | Therapeutic Composition and Use - The use of liquid formulations in the preparation of a medicament for the prevention and treatment of oral, gastric and digestive infections and in particular for the prevention of ventilator associated pneumonia as well as liquid enteral and parenteral tube feeding compositions. The feeding compositions are suitable for use in the prevention of ventilator associated pneumonia. | 2009-12-24 |
20090317493 | Trehalose-containing topical drying composition and method of using same - A topical drying composition is providing containing trehalose as the effective moisture (sweat) removing ingredient. The composition may be used in aqueous form or preferably as a cream and in addition to trehalose it contains several ingredients such as sorbitan monolaurate, polysorbitan, a moisturizer, a thickener, a softener, an antibacterial agent and a pH adjusting component to adjust the pH of the composition between about 5.5 to about 7.5. Sterilized water is used as the carrier for the composition. | 2009-12-24 |
20090317494 | Herbal composition containing COX-2 and its manufacturing method - A herbal composition, containing natural COX-2, includes a powder of Labiatae plant, wherein the herbal composition is prepared by a method including the steps of dehydrating the Labiatae plant and grinding the dried Labiatae plant into a powdered form. The herbal composition is used for treatment of a disease including Nephritis, Lymphoma and colorectal cancer, Acute, chronic, and bile-reflux cholecystitis, and aphonia. The herbal composition is formed as an internal treatment having an administrative form selected from the group consisting of capsule, powder, solution, and syrup. The herbal composition is formed as an external treatment by mixing the powdered Labiatae plant with “Vaseline”. | 2009-12-24 |
20090317496 | Method for Preventing and Treating the Disease Caused by Vascular Damage and the Use Thereof - The present invention relates to compositions containing an extract of processed | 2009-12-24 |
20090317497 | Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders - Compositions, kits and methods are provided for promoting brain and cardiovascular health, preventing or treating neurological and vascular disorders. In one embodiment, the composition comprises | 2009-12-24 |
20090317498 | COMPOSITION COMPRISING EXTRACT OF CINNAMOMUM CASSIA BARK FOR IMPROVING NORMAL FLORA AND ENHANCING IMMUNE RESPONSE - The present invention relates to a composition for improving intestinal flora and enhancing immune response containing | 2009-12-24 |
20090317499 | Artemisinins in the clinical and veterinary management of kinetoplastid infections - The invention relates to the treatment of kintoplastid infections by administering a pharmaceutical composition containing an extract from the plant | 2009-12-24 |
20090317500 | PESTICIDE AND REPELLANT - A pesticide or repellent comprising a liquid concentrate obtained from garlic juice by the removal of water from the juice. | 2009-12-24 |
20090317501 | Pinus Pinea Plant Extracts For Treating Osteoporosis and the Extraction Process Thereof - The present invention is concerned with nutritional or pharmaceutical compositions comprising extracts or concentrates of plants and the mixtures thereof belonging to | 2009-12-24 |
20090317502 | DANDRUFF TREATMENT COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS INCLUDING BOTANIC SEED OILS - Compositions including a topical steroid, a blend of concentrated botanic seed oils, and a suitable vehicle for topical application to the skin are described. Compositions of the present invention can be used as a therapeutic method for treating skin conditions, including scalp conditions such as dandruff. The compositions are topically administered to the affected area of the skin of a mammal in need of such therapy. | 2009-12-24 |
20090317503 | Eyelid Preparation and Method of Use - Embodiments of the invention comprise an eyelid preparation, a method for producing the eyelid preparation, a method for treating or preventing eyelid conditions and a method for applying an eyelid preparation on human eyelids or eyelashes. The eyelid preparation may be used to treat ocular conditions, such as blepharitis, dry eyes and dysfunctions of the meibomian glands, associated with an infestation of Demodex mites. The eyelid preparation consists essentially of therapeutically effective amounts of an essential oil and a dermatologically acceptable carrier. | 2009-12-24 |
20090317504 | DEVICE AND METHOD FOR PRODUCING NANOPARTICLES - The invention relates to a device and a method for producing nanoparticles, in which method starting materials for nanoparticles are mixed at least as liquid droplets and optionally also as gases and/or vapours with at least combustion gases in a premixing chamber and the mixture is separated for liquid drops larger than size d, whereafter the mixture is conducted to at least one burner, in which the combustion gases are ignited such that a heavily mixing flame is generated, in which the starting materials react and optional solvents evaporate and generate through nucleation and/or sintering and/or agglomeration particles having a diameter of 1 to 1000 micrometres. | 2009-12-24 |
20090317505 | DEVICE FOR DRAWING FILAMENTS - A device for drawing melt-spun filaments for forming a spunbonded fabric includes at least one guide member. The filaments are guided through a slot-shaped nozzle, onto which compressed air is applied, and which conveys the filaments through the drawing nozzle. Guide members are provided on both sides of the slot on the base of the slot-shaped outlet, which cause a uniform structure of the fabric due to their shaping. This is achieved when a guide member has a plurality of notches parallel to the conveying direction, and the opposite guide member has a plurality of bores, which passively connect the space between the guide member with the environment. | 2009-12-24 |
20090317506 | FURNACE AND EQUIPMENT FOR PRODUCING STERILE VESSELS FROM DECONTAMINATED PREFORMS OF A THERMOPLASTIC MATERIAL - The invention relates to a thermal conditioning furnace ( | 2009-12-24 |
20090317507 | Press for producing powder based parts using compaction - A press for producing parts, such as high precision ceramic parts or powder metal parts, by compaction of material. The press comprises a frame having a longitudinal axis, a die and a punch assembly mounted on the frame, and a motion assembly adapted to move the punch assembly relative to the die along the axis. The punch assembly comprises a plate and a punch held by the plate and extending along the axis. The plate comprises a central portion via which the axis passes and distal portions on two sides of the central portion. The motion assembly comprises two linear motion mechanisms, each comprising a threaded shaft with a portion thereof received within one of the distal portions, and a nut assembly mounted on the threaded shaft and engaging the distal portion within which the threaded shaft is received. Each nut assembly comprises a nut housing surrounding a portion of the threaded shaft, and a plurality of ribbed rollers disposed therebetween in a planetary arrangement and engaging both. The rotational motion is provided to either both of the nut assemblies or both of the threaded shafts, causes linear motion of the punch assembly with the punch along the axis, for the compaction of powdered material contained within the die. | 2009-12-24 |
20090317508 | MOLD CLEARING TOOL - A mold clearing tool includes a support portion and a draft portion. The support portion includes a bracket and two poles extending downward from two ends of the bracket. The bracket includes a second through hole defined therein. The draft portion includes a main body and a spiral draft end on one end of the main body. The spiral draft end is threaded outside. The draft portion is movably received through the second through hole for clearing excess material remaining in a molding chamber. The molding chamber includes a plurality of first through holes defined therein. | 2009-12-24 |
20090317509 | Satiety emulsions and food compositions - The present invention provides edible aqueous oil-in-water emulsions comprising 15-70% wt oil having a saturated fatty acid content of at least 20% wt, 0.1-5% wt of an emulsifier system. The oil preferably comprises hydrogenated and unhydrogenated rapeseed oil and the emulsifier system preferably comprises milk protein and monoglycerides. The emulsions provide good satiety benefits and do not adversely affect the taste of products into which they are incorporated. Also provided are food and beverage products comprising the emulsion of the invention. | 2009-12-24 |
20090317510 | LOW SODIUM, HIGH CALCIUM, PROTEIN HYDROLYSATE FLAVOR ENHANCER AND A METHOD PREPARE THEREOF - A method to produce flavor enhancer comprises the steps of hydrolyzing protein source in presence of catalysts at an operating temperature of 25° C. to 60° C. and pH 4 to 8 to form hydrolysate; or using strong acid on defatted protein source at high temperature above 95° C.; maintaining the pH of the hydrolyzing process; deactivating the catalysts in the hydrolysate; adjusting pH of the hydrolysate to 3.5-4.5 with calcium carbonate or acid; and filtering the hydrolysate through layers of activated carbon and/or calcium carbonate to obtain the flavor enhancer. | 2009-12-24 |
20090317511 | PROCESS FOR PRODUCING FLAVOR ENHANCER FOR BEER AND BEER-LIKE BEVERAGE AND BEVERAGE OF A ROAST MATERIAL - The present invention relates to a process for producing a flavor enhancer for beer and beer-like beverage and beverage of a roast material, which includes (1) heating a grinded matter of a cereal, (2) treating the grinded matter with protease, and (3) recovering an extract; and a flavor enhancer for beer and beer-like beverage and beverage of a roast material obtainable by the process. The flavor enhancer of the invention can be used for enhancing the full body and enhancement of beer and beer-like beverage and beverage of a roast material. | 2009-12-24 |
20090317512 | Vegetable protein concentrate - This invention relates to a process for preparing a vegetable protein concentrate from oleaginous vegetable material that comprises the steps of: | 2009-12-24 |
20090317513 | Amylose and Amylopectin Derivatives - Disclosed herein is a method for harvesting amylose host material comprising enzymatically treating starch after the starch has been chemically modified to uniformly insert a steric hindrance substituent. | 2009-12-24 |
20090317514 | Process For Making A Shelf-Stable Milk Based Beverage Concentrate - A concentrate, system and low-temperature process for preparing a shelf-stable milk concentrate that does not require ultra-high temperature thermal processing for control of the microbiology of the product is disclosed herein. The method preferably incorporates aseptic technology and the enzymatic reduction of lactose to control water activity. The method preferably includes the enzymatic conversion of the lactose in the milk to its component sugars glucose and galactose, which preferably changes the colligative properties of the concentrate, decreases the amount of free water, and reduces the osmolarity. | 2009-12-24 |
20090317515 | SOLID ENZYME FORMULATIONS AND PROCESS FOR THEIR PREPARATION - The present invention relates to novel solid enzyme formulations comprising mixtures of at least one salt-stabilized enzyme composition, at least one particulate support and at least one hydrophobic liquid. In addition, the invention relates to methods for producing such solid enzyme formulations and also animal feed, foods and food supplements which comprise such enzyme formulations. | 2009-12-24 |
20090317516 | PULVERLUENT MIXTURE THAT IS PALATABLE TO THE TASTE EVEN THOUGH SOME OF ITS INGREDIENTS MAY OTHERWISE TASTE BITTER IF TASTED SEPARATELY - An edible item, which may be a food or nutritional supplement, that is palatable to the taste with a palatably pleasant aftertaste and is a mixture of pre-processed components in a granular or heterogeneous mixture. When added with a liquid such as water or milk, the heterogeneous mixture forms a batter that may be cooked into a shape indicative of a pancake. At least one of the pre-processed components segregates from the remainder of the cooked batter. It does not dissolve as a result of the addition of the liquid. | 2009-12-24 |
20090317517 | FAT CONTAINING EDIBLE EMULSIONS WITH IRON AND ZINC - Edible emulsion comprising 5 to 85 wt % fat and between 0.003 wt % and 0.7 wt % of iron and between 0.002 wt % and 0.3 wt % of zinc. | 2009-12-24 |
20090317518 | Beverage Cartridge - A cartridge containing one or more beverage ingredients and comprising an inlet for the introduction of an aqueous medium and an outlet for the beverage produced from the one or more beverage ingredients, the cartridge incorporating within a beverage flow path between the inlet and the outlet an eductor for entraining air into the beverage, the eductor comprising an aperture for producing a low pressure jet of the beverage. | 2009-12-24 |
20090317519 | Beverage displaying an edible printed design image thereupon, and a method for production thereof - The present invention discloses a beverage displaying a printed design image upon a foamed portion of the beverage. The invention further discloses a device and method for same. In the invention, an automated printer is used, comprising a movable printing head, loaded with an edible liquid ink, to print a design of interest upon the beverage foam. In some embodiments, the beverage is coffee and the liquid ink is a second coffee essence. The invention additionally discloses business methods comprising printing an advertisement upon a foamed portion of a beverage, or selling a beverage displaying a printed image upon a foamed portion of the beverage. | 2009-12-24 |
20090317520 | Vegetable Containing Food Product and Method of Making - A method is disclosed for producing a vegetable containing half product and final product. The vegetable containing food products have a high content of non-potato vegetable puree and can be made to resemble French fries. The vegetable containing food product and half product can be easily inserted into the supply chain of a quick service restaurant for efficient delivery to the consumer. | 2009-12-24 |
20090317521 | Color-Coated Flavour Encapsulate Particles - The present invention relates to the field of flavoured particulate food and/or beverage compositions. More in particular it relates to such compositions incorporating flavour encapsulate particles, which have been adapted in such a way that they appear to be similar to the particles contained in said food or beverage compositions as used without additional flavouring. These and further objects have been realized by the present invention by providing flavour encapsulate particles comprising a core particle coated with an inner coating layer comprising one or more flavourings contained in a carrier matrix and an outer coating layer comprising a substantial amount of an extract a plant material. Said outer coating contains substantial amounts of colouring substances naturally present in the plant material. | 2009-12-24 |
20090317522 | Food Product Having a Casing - The present invention is directed to a process for preparing a food product having a casing, the process comprising the step of applying a casing paste comprising alginate and a sparingly soluble calcium salt by co-extrusion to the exterior of a material to be cased to form a co-extruded product, and contacting the co-extruded product with a solution comprising calcium ions, thereby causing the alginate to gel. | 2009-12-24 |
20090317523 | METHODS FOR PREPARING FREEZE DRIED FOODS - The present invention relates to a process of manufacturing dried plant products to be used as additives in food. This invention addresses the issue of reducing the cost of freeze-drying plant material while retaining the desired characteristics of the edible plant material. | 2009-12-24 |
20090317524 | PRODUCTION OF EDIBLE WAFERS BY EXTRUSION - A method for producing wafers by extrusion comprising the steps of a. Preparing an ingredient mix b. Feeding the mix in an extruder and cooking the mix c. Extruding the cooked mix such that an extruded and expanded non-planar structure is formed d. Unfolding the structure to give a large extruded sheet e. Subjecting the extruded sheet to stretching/pulling f. Adjusting the sheet in order to obtain a desired thickness g. Drying the sheet h. Separating the sheet into wafers of desired dimensions The invention also relates to the wafers thus produced and to a wafer production line. | 2009-12-24 |
20090317525 | PROCESS FOR PREPARATION OF SAFFRON CREAM LIQUEUR - The process for the preparation of Saffron Cream Liqueur comprising:—preparing saffron concentrate by adding saffron 1-5 gm. in one liter of ENA (extra neutral alcohol) of 68% OP, i.e., 96% v/v,—intermittently stirring the said mixture of ENA and saffron for 18-36 hours, extracting the essential oil containing aroma, color and flavor,—filtering the said mixture of saffron and the ENA to obtain the saffron concentrate, diluting the said concentrate from 68% OP to −9-45% by adding demineralized water at room temperature, adding about 5-15% food grade white milk cream and properly mixing it, adding about 5-20% food grade sugar and mix till sugar is dissolved,—adding about 1-5% food grade flavoring agent and mixing it thoroughly and filtering to get saffron cream liqueur. | 2009-12-24 |
20090317526 | COFFEE BREWING SYSTEM - A device for brewing coffee including a basket for retaining coffee grounds, the basket having an opening to receive water at a user-selected temperature for contacting the coffee grounds within the basket. A control valve is provided for controlling the discharge of brewed coffee from the basket only after all of the water intended to be brewed has steeped within the coffee grounds. | 2009-12-24 |
20090317527 | APPARATUS FOR PRODUCING A BEVERAGE - An apparatus is provided for producing a beverage from concentrate. A mixing chamber is included. A water tank and a concentrate container provide water and concentrate. A water conduit is horizontally oriented and is connected to the water tank to supply water from the water tank to the mixing chamber by gravity. A concentrate conduit extends from the concentrate container and at an acute angle to the water conduit and then extends generally parallel to the water conduit and in close proximity to the water conduit. The mixing chamber is connected to both the water conduit and the concentrate conduit. Both the concentrate conduit and the water conduit have an outlet end. Each outlet end is remote from the water tank and the concentrate container. The outlet end of the concentrate conduit is adjacent to the outlet end of the water conduit. A dispenser assembly is mounted on the mixing chamber. A strength valve is located in the concentrate conduit adjacent to the mixing chamber to control the flow of concentrate. An electrical circuit is provided including a means for adjusting the temperature of the water. | 2009-12-24 |
20090317528 | METHOD AND APPARATUS FOR PRODUCING A CONFECTIONARY PRODUCT FROM MULTIPLE COMPONENTS - The present invention relates to a method of producing a molded confectionery product, comprising the steps of transferring a fat-containing confectionery mass and a water carrier, blending the fat-containing confectionery mass and the water carrier in a mixer to a substantially homogeneous blended mass, and depositing the blended mass in at least one mould or onto a conveyor belt. The above steps are performed within 60 seconds or less. The apparatus for producing a molded confectionery product comprises channels for transferring of a fat-containing confectionery mass and a water carrier, a mixer for blending the fat-containing confectioner mass and the water carrier to a substantially homogeneous blended mass, and at least one mixing nozzle for depositing of the blended mass. | 2009-12-24 |
20090317529 | Aromachemicals and Processes for Preparation - Aromachemical compounds of Formula I, compositions comprising these compounds and processes for their preparation are disclosed, | 2009-12-24 |
20090317530 | PROTEIN-RICH PREMIX POWDERS COMPRISING OKARA FOR HEALTHY FOOD INDUSTRY - A stable okara concentrate is provided, being a protein-rich powder to be used in producing healthy foodstuffs, enriched in proteins, dietary fibers, and free of cholesterol, essentially consisting of natural materials not contacted with any toxic or harmful substances during their production. Useful premixes for use in food industry or household are also provided. The concentrate may be made from a by-product obtained in soybeans processing. Food products comprising the okara concentrate are also provided. | 2009-12-24 |
20090317531 | SELF-FOAMING LIQUID CULINARY AIDS AND PROCESSES - Described is a self-foaming, liquid culinary aid including a first liquid component including an edible acid component, and a second liquid component comprising an edible salt, each liquid being shelf-stable and being operatively associated so that when the first and second liquids are combined carbon dioxide evolves to assist in providing the foam so that, when the liquid culinary aid is combined with the food product, the culinary aid melts or disperses in less than about 20 seconds in the food product to impart a foaming texture to the food product. | 2009-12-24 |
20090317532 | Compositions containing non-polar compounds - Provided herein are compositions and methods for preparing foods and beverages that contain additives. Additives include nutraceuticals, pharmaceuticals, and supplements, such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including Coenzyme Q10, and other oil-based additives. | 2009-12-24 |
20090317533 | METHOD FOR PRODUCING A SOY MILK - A method of production of a soymilk or a soy-based beverage. The method includes the following processing steps: providing soybeans for processing; soaking the soybeans; grinding the soybeans to form a slurry; separating the soy slurry into soymilk and okara in a centrifugal field. The soaking and grinding are carried out at temperatures from 0° C. to 40° C., which temperatures yield native proteins. Further included is a step of deodorizing the soymilk to reduce the beany taste. | 2009-12-24 |
20090317534 | HYBRID CORN PLANT AND SEED PP59601 - This invention provides hybrid maize plant designated PP59601. This invention further provides hybrid seed of PP59601, hybrid plants produced from such seed, and variants, mutants, and trivial modifications to hybrid PP59601, as well as methods of using the hybrid and products produced from the hybrid. | 2009-12-24 |
20090317535 | GENETICALLY MODIFIED PLANTS WHICH SYNTHESIZE A LOW AMYLOSE STARCH WITH INCREASED SWELLING POWER - The present invention relates to genetically modified monocotyledonous plant cells and plants whose starch has an apparent amylose content of less than 5% by weight and an increased activity of a protein with the activity of a starch synthase II and an increased activity of a protein with the activity of a glucan, water dikinase. Such plants synthesize starch with an increased hot-water swelling power. Methods and processes for the generation/preparation of these plant cells, plants, starches and flours are likewise subject matter of the present invention. | 2009-12-24 |
20090317536 | Flavour Enhancing Fractionated Tomato Extract and Compositions Comprising the same - The present invention relates to natural flavour enhancing extracts and compositions comprising the same, for use in foodstuffs and beverages and to a method for producing such extracts. More in particular, the invention provides improved umami taste imparting fractionated tomato extracts having some very special characteristics with regard to the levels and/or ratios of sugars, amino acids and organic acids. The fractionated tomato extracts of the invention are produced by using nano filtration fractionation. The products so obtained posses improved taste enhancing and/or augmenting (umami) effects and are near colourless and essentially devoid of tomato taste and smell. Thus, unlike the prior art products known, this product can be applied in foods in substantial quantities without concomitantly causing any redness of the product and without imparting tomato-like smell or taste. | 2009-12-24 |
20090317537 | Method and System for Selective Coating of Endoluminal Prostheses - A system and method for coating an endoprosthesis involves an applicator capable of delivering a coating substance to the endoprosthesis without spraying. The applicator may have a tube or die through which a coating substance is moved upwards by capillary action or by means of a pump so as to form an accumulation of the coating substance at an upper portion of the applicator. The endoprosthesis can be lowered onto the accumulation, then axially translated or rotated in order to transfer the coating substance to selected portions of the endoprosthesis. The applicator is lowered and/or the endoprosthesis is raised in order to form gaps in the coating. Selective coating of abluminal or luminal surface of the endoprosthesis may also be performed by allowing the surface to skip on a liquid surface of a pool of the coating substance. | 2009-12-24 |
20090317538 | BIOLOGICALLY ACTIVE IMPLANTS - This invention relates to an implant for treating pathological changes in the spinal column and/or locomotor system. According to one embodiment of the invention, the implant has a surface, a body, and an enamel-like or varnish-like coating that is up to 100 μm thick, comprises a biodegradable polymer such as polylactide which has a mean molecular weight of 100 kDa or less, forms an adhesive bond to the surface of the body such that when the implant is implanted, mechanical friction will not abrade or damage the coating, and is adapted to contact bone when implanted. This coating has an osteoinductive effect, which promotes the healing of fractures. Additional osteoinductive materials such as growth factors may be incorporated in the coating. The invention also relates to a method for producing such an implant using the following steps: preparing a dispersion of a biodegradable polymer in an organic solvent; applying the dispersion on the surface to be coated; and allowing the organic solvent to evaporate. | 2009-12-24 |
20090317539 | Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element - It is an object to provide a composition in which an anthracene derivative is dissolved and a technique in which a thin film that has a favorable film quality is formed by a wet process using the composition. In addition, it is another object to manufacture a highly reliable light-emitting element using the composition at low cost with high productivity. A composition having a solvent and an anthracene derivative having one anthracene structure and one carbazolyl group which is bonded to the anthracene structure directly or through a phenyl group is formed. A thin film with a favorable film quality can be formed by a wet process using the composition. Accordingly, a highly reliable light-emitting element can be manufactured using such a thin film. | 2009-12-24 |
20090317540 | Methods Of Forming A Non-Volatile Resistive Oxide Memory Array - A method of forming a non-volatile resistive oxide memory array includes forming a plurality of one of conductive word lines or conductive bit lines over a substrate. Metal oxide-comprising material is formed over the plurality of said one of the word lines or bit lines. A series of elongated trenches is provided over the plurality of said one of the word lines or bit lines. A plurality of self-assembled block copolymer lines is formed within individual of the trenches in registered alignment with and between the trench sidewalls. A plurality of the other of conductive word lines or conductive bit lines is provided from said plurality of self-assembled block copolymer lines to form individually programmable junctions comprising said metal oxide-comprising material where the word lines and bit lines cross one another. | 2009-12-24 |
20090317541 | FUNCTIONAL SILANE COMPOUND, COATING SOLUTION, AND METHOD FOR MANUFACTURING PLASTIC LENS - A functional silane compound is provided. The functional silane compound realizes a coat film having both adhesiveness and abrasion resistance and allowing a reaction thereof to be easily controlled. The functional silane compound includes silicon with a hydrolyzable functional group formed at the end of a chain molecule and one or more urea bonds in the middle of the chain molecule. | 2009-12-24 |